Mechanistically, miR-452 binds to the 3′-UTR of WWP1 to inhibit its expression, thereby reducing WWP1-mediated proliferation, migration, and invasion of prostate cancer cells (Fig. 6B, [137]). The gene discussed is WWP1; the disease is prostate carcinoma.